DBTX - Decibel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $11.81. This is a potential upside of $6.9 (140.53%) from yesterday's end of day stock price of $4.91.

Decibel Therapeutics's activity chart (see below) currently has 23 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by JACK ALLEN from BAIRD on 10-Aug-2023. First documented stock forecast 09-Mar-2021.

Best performing analysts who are covering DBTX - Decibel Therapeutics:

Mani Foroohar Joseph Pantginis Jack Allen Matthew Luchini Gena Wang Neena Bitritto-Garg

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 10-Aug-2023

$5.25

$0.34 (6.92%)

$21

2 years 5 months 13 days ago
(10-Aug-2023)

0/2 (0%)

$0.09 (1.74%)

Hold

Since 09-Aug-2023

$23

2 years 5 months 14 days ago
(09-Aug-2023)

0/1 (0%)

$15.49 (206.26%)

Buy

Since 09-Mar-2021

$2

$-2.91 (-59.27%)

$7

2 years 10 months 8 days ago
(15-Mar-2023)

0/5 (0%)

$-1.51 (-43.02%)

Buy

Since 09-Mar-2021

$10

$5.09 (103.67%)

3 years 2 months 13 days ago
(10-Nov-2022)

0/3 (0%)

$6.84 (216.46%)

Buy

Since 09-Mar-2021

$7

$2.09 (42.57%)

$30

3 years 10 months 2 days ago
(21-Mar-2022)

0/2 (0%)

$3.97 (131.02%)

Show more analysts

Please expand the browser size to see the chart

What is DBTX (Decibel Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on DBTX (Decibel Therapeutics) with a proven track record?

MANI FOROOHAR

Which analyst has the current lower performing score on DBTX (Decibel Therapeutics) with a proven track record?

NEENA BITRITTO-GARG

Which analyst has the most public recommendations on DBTX (Decibel Therapeutics)?

Mani Foroohar works at LEERINK and has 11 price targets and 8 ratings on DBTX

Which analyst is the currently most bullish on DBTX (Decibel Therapeutics)?

Matthew Luchini with highest potential upside - $19.09

Which analyst is the currently most reserved on DBTX (Decibel Therapeutics)?

Mani Foroohar with lowest potential downside - -$2.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?